Osaic Holdings’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Hold |
0
| – | -$1 | – | 8038 |
|
|
2025
Q4 | – | Sell |
-5
| Closed | -$130 | – | 7814 |
|
|
2025
Q3 | $50 | Buy |
+5
| New | +$461 | ﹤0.01% | 7786 |
|
|
2025
Q2 | – | Sell |
-1
| Closed | -$141 | – | 7612 |
|
|
2025
Q1 | $120 | Hold |
1
| – | – | ﹤0.01% | 7218 |
|
|
2024
Q4 | $297 | Hold |
1
| – | – | ﹤0.01% | 7124 |
|
|
2024
Q3 | $232 | Buy |
+1
| New | +$358 | ﹤0.01% | 7153 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$661 | – | 7221 |
|
|
2024
Q1 | $733 | Hold |
1
| – | – | ﹤0.01% | 6746 |
|
|
2023
Q4 | $900 | Hold |
1
| – | – | ﹤0.01% | 6787 |
|
|
2023
Q3 | $911 | Hold |
1
| – | – | ﹤0.01% | 6847 |
|
|
2023
Q2 | $2.06K | Hold |
1
| – | – | ﹤0.01% | 6655 |
|
|
2023
Q1 | $2.65K | Hold |
1
| – | – | ﹤0.01% | 6600 |
|
|
2022
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 6708 |
|
|
2022
Q3 | $6K | Hold |
1
| – | – | ﹤0.01% | 6300 |
|
|
2022
Q2 | $7K | Hold |
1
| – | – | ﹤0.01% | 6323 |
|
|
2022
Q1 | $14K | Hold |
1
| – | – | ﹤0.01% | 5947 |
|
|
2021
Q4 | $11K | Hold |
1
| – | – | ﹤0.01% | 6197 |
|
|
2021
Q3 | $23K | Hold |
1
| – | – | ﹤0.01% | 5678 |
|
|
2021
Q2 | $24K | Hold |
1
| – | – | ﹤0.01% | 5548 |
|
|
2021
Q1 | $34K | Buy |
+1
| New | +$57.3K | ﹤0.01% | 5151 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5408 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5891 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5980 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5909 |
|
Other funds holding DCOY
Osaic Holdings's DCOY Position: Q1 2026 in Review
Osaic Holdings held its Decoy Therapeutics (DCOY) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8038.
Osaic Holdings first reported a position in DCOY in Q1 2021 and has held it in 17 quarters since. The position peaked at $34K in Q1 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q1 2026.
- Osaic Holdings held 0 shares of Decoy Therapeutics worth $0 as of Q1 2026.
- Osaic Holdings left its Decoy Therapeutics share count unchanged in Q1 2026.
- Decoy Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #8038 holding.
- Osaic Holdings first reported a position in Decoy Therapeutics in Q1 2021 and has held it in 17 quarters since.
- Osaic Holdings's Decoy Therapeutics position peaked at $34K in Q1 2021.
- 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.